Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...

The U.S. and its major trading partners have agreed to reciprocal tariff elimination for pharmaceutical products and chemicals used in drug production for the past 30 years, according to the U.S ...

For years, Jeff Simmons — the president and CEO of the large US pharmaceutical company Elanco — ridiculed a seemingly unlikely target on social media: the plant-based meat industry.

Key Project Highlights: Strong Investor Backing: $9 million raised from Amber, DePIN X, Water Drip, JDI, GOBI Partners, MEEZAN, PrimeLink, NeoVentures, and others. Successful Public Sale ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

2025 will be a challenging year for many sectors with multiple headwinds, and the pharmaceutical industry is no exception. The industry is grappling with significant market shifts amidst emerging ...

LONDON/JOHANNESBURG/GENEVA, Feb 27 (Reuters) - U.S.-funded projects worldwide, including those providing lifesaving care for millions of people in countries such as Sudan and South Africa ...

pharmacy a related scientific or healthcare discipline. We may consider non-graduates with professional experience and academic ability. See the advice to applicants section for more information. You ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.

Forbes contributors publish independent expert analyses and insights. Kathleen Walch covers AI, ML, and big data best practices.